Randomized clinical trials in advanced and metastatic colorectal carcinoma Article Report uri icon

Overview

MeSH Major

  • Colorectal Neoplasms
  • Liver Neoplasms
  • Randomized Controlled Trials as Topic

abstract

  • The treatment of advanced colorectal cancer has long been a dilemma for clinicians. After many years of therapy limited to 5-fluorouracil (5-FU)-based chemotherapy, a number of new discoveries have significantly advanced this field in the last decade. The advent of irinotecan has given us hope for a second line chemotherapeutic agent and a possible new combination for first line chemotherapy.

publication date

  • January 15, 2002

Research

keywords

  • Report

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1055-3207(03)00080-2

PubMed ID

  • 11928799

Additional Document Info

start page

  • 173

end page

  • 91, ix

volume

  • 11

number

  • 1